tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of David Lewis, 159 are a BUY (52.82%), 128 are a HOLD (42.52%), 14 are a SELL (4.65%).
Analyst David Lewis, carries an average stock price target met ratio of 83.81% that have a potential upside of 16.9% achieved within 269 days. Previously, David Lewis worked at MORGAN STANLEY.
David Lewis’s has documented 445 price targets and ratings displayed on 25 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on ABT, Abbott Laboratories at 17-Oct-2024.
Analyst best performing recommendations are on SWAV (SHOCKWAVE MEDICAL).
The best stock recommendation documented was for ABMD (ABIOMED) at 2/11/2020. The price target of $165 was fulfilled within 2 days with a profit of $10.82 (6.15%) receiving and performance score of 30.77.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$380
$-1.02 (-0.27%)
$235
2 years 4 months 29 days ago
(02-Nov-2022)
1/2 (50%)
$6.49 (1.74%)
36
Hold
$388
$6.98 (1.83%)
$355
2 years 4 months 29 days ago
(02-Nov-2022)
2/5 (40%)
$14.49 (3.88%)
88
Hold
$380
$-1.02 (-0.27%)
$350
2 years 4 months 30 days ago
(01-Nov-2022)
24/41 (58.54%)
$2.18 (0.58%)
138
Buy
$300
$-81.02 (-21.26%)
$425
2 years 5 months 18 days ago
(13-Oct-2022)
1/2 (50%)
$41.92 (16.24%)
19
Sell
$235
$-146.02 (-38.32%)
$275
2 years 8 months 16 days ago
(15-Jul-2022)
6/8 (75%)
$-33.23 (-12.39%)
143
Which stock is David Lewis is most bullish on?
What Year was the first public recommendation made by David Lewis?
